CRDF vs NTRS · rev $145.0K vs P/E 18, rev $2.69B
Cardiff Oncology Inc (CRDF) versus Northern Trust Corporation (NTRS) — a side-by-side from cached financials, not a winner call.
Cardiff Oncology Inc (CRDF) is a biotechnology company listed on US.
Northern Trust Corporation (NTRS) is a asset management company listed on US.
Latest reported CRDF revenue for 2026-06-30 was $145.0K. Net income was -$21.6M. CRDF currently screens at market cap $238.8M.
Latest reported NTRS revenue for 2026-06-30 was $2.69B. Net income was $1.32B. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
CRDF currently screens at market cap $238.8M. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
Not investment advice. Open the CRDF and NTRS stock pages for the full models.
Not investment advice.